![Gerd Auffarth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerd Auffarth
Direktör/Styrelseledamot på
OUTLOOK THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-06-30
Profil
Gerd U.
Auffarth is currently Chief Executive Officer at Steinbeis-transferzentrum.
Since 2011, the Chairman of the Ophthalmology Department at Ruprecht-Karls-Universität Heidelberg.
Director at The European Society of Cataract & Refractive Surgeons since 2005.
Independent Director at Outlook Therapeutics, Inc. since 2020.
Director at International Vision Correction Research Centre since 2006.
Director at David J Apple International Laboratory For Ocular Pathology since 2012.
Director at German Ophthalmological Society since 2012.
President at Deutschsprachige Gesellschaft Fur Intraokularlinsen since 2012.
Former Independent Director at Presbia PLC.
Education includes doctorates from RWTH Aachen University (1990) and Ruprecht-Karls-Universität Heidelberg.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-18 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Gerd Auffarth
| Företag | Position | Start |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-04-20 |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2011-04-01 |
International Vision Correction Research Centre | Direktör/Styrelseledamot | 2006-08-01 |
The European Society of Cataract & Refractive Surgeons
 The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Direktör/Styrelseledamot | 2005-09-01 |
David J Apple International Laboratory For Ocular Pathology | Direktör/Styrelseledamot | 2012-06-01 |
German Ophthalmological Society | Direktör/Styrelseledamot | 2012-09-01 |
Steinbeis-transferzentrum | Verkställande Direktör | - |
Deutschsprachige Gesellschaft Fur Intraokularlinsen | President | 2012-03-01 |
Tidigare kända positioner av Gerd Auffarth
| Företag | Position | Slut |
|---|---|---|
| PRESBIA PLC | Direktör/Styrelseledamot | - |
Gerd Auffarths utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
RWTH Aachen University
 RWTH Aachen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Society of Cataract & Refractive Surgeons
The European Society of Cataract & Refractive Surgeons Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for cataract and refractive surgeons | Commercial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Steinbeis-transferzentrum | |
Presbia PLC
 Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
International Vision Correction Research Centre | |
David J Apple International Laboratory For Ocular Pathology | |
German Ophthalmological Society | |
Deutschsprachige Gesellschaft Fur Intraokularlinsen |
